Also, a study assessing the impact of L-arginine and selenium supplementation on women with central obesity revealed that selenium markedly reduced fasting insulin levels and enhanced insulin sensitivity, thereby emphasizing its potential utility in addressing obesity-related metabolic disorders (63). This evidence concerns the gene INS and obesity disorder.